Stockreport

FDA grants approval for Bristol Myers Squibb's Augtyro for solid tumours [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF tyrosine receptor kinase (NTRK)-positive locally advanced or metastatic solid tumours. The treatment is indicated for use in adult and paediatric patients aged 12 year [Read more]